9 matches for your search in the start-up spotlight
rss
More hope for pregnancy: Ovo Labs secures 4 million pounds in start-up capital
05-May-2025
Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain ...
First closing of KHAN Technology Transfer Fund II GmbH & Co KG “KHAN-II”
12-Feb-2025
Khanu Fondsverwaltung GmbH (Khanu), a drug discovery focused fund management team, announces the first closing in fundraising for KHAN Technology Transfer Fund II GmbH & Co KG (KHAN-II), the follower fund of KHAN-I (vintage year 2019). As limited partners of KHAN-II, the European Investment Fund ...
2022 brought record investment sums for research-based start-ups managed by Max Planck Innovation
21-Mar-2023
A successful business year for Max Planck Innovation includes increasing investment sums for the start-ups managed. Especially life sciences start-ups with a high degree of maturity provided a record sum of 225 million euros. Companies in the Max Planck Innovation investment portfolio raised over ...
Batene starts with ten million euros in seed financing
16-Nov-2022
An invention by researchers at the Max Planck Institute for Medical Research could make batteries much more energy dense, efficient and safer. The research team has found a way to produce very fine metal fleeces, the batene fleece, that can serve as current collectors in batteries and make them ...
Cutanos, a spin-off from the Max Planck Society, is developing novel vaccines and immunotherapies
06-Jul-2021
In the future, it could be possible to stimulate the immune system with extremely high efficacy via the skin. Cutanos GmbH, a spin-off from the Max Planck Institute of Colloids and Interfaces, has developed a corresponding method for modulating immune cells in the skin. The LC-TDS technology ...
Launch of Start-up QLi5 Therapeutics
18-Jun-2020
The Lead Discovery Center GmbH (LDC) and the South Korean drug development specialist Qurient have founded QLi5 Therapeutics GmbH, together with their partners, the Max Planck Society (MPG) and Nobel laureate Prof. Huber, emeritus director of the Max Planck Institute for Biochemistry. Dortmund ...
Scientists are developing a procedure whereby vaccines can be absorbed through the skin
14-May-2020
The Max Planck Institute of Colloids and Interfaces in Potsdam and the Technology Transfer Fund KHAN-I are developing a vaccine procedure for SARS-CoV2 together with the Lead Discovery Center in Dortmund. The researchers hope that within the next few years, they will be able to establish immunity ...
Startup will promote innovative approach to clinical trials in HIV treatment
30-Apr-2020
Hamburg-based researchers are seeking to improve future treatment of HIV patients using a new gene and cell method. Under the umbrella of Hamburg biotech startup Provirex, they are developing a new therapeutic approach that uses ‘gene scissors’ to cut out the blueprint of the AIDS pathogen HIV ...
Start-up Quench Bio closes USD 50M Series A financing
28-Feb-2020
The Lead Discovery Center GmbH (LDC), the Max Planck Society (MPG) and Max Planck Innovation (MI) announce that their associated company Quench Bio Inc., Cambridge, USA has raised USD 50 million in a Series A financing round. The financing was led by RA Capital Management (RA Capital) and ...
